Universe Pharmaceuticals annual return on equity
2020
2021
2022
2023
2024
2025
Universe Pharmaceuticals Return on Equity (ROE) Growth & History (UPC)
Universe Pharmaceuticals's return on equity was −7.23% for fiscal 2025.
View full Universe Pharmaceuticals company overviewUniverse Pharmaceuticals annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-09-30 | −7.23% | +16.53 pp |
| 2024 | 2024-09-30 | −23.76% | −23.71 pp |
| 2023 | 2023-09-30 | −0.05% | +19.17 pp |
| 2022 | 2022-09-30 | −19.22% | −52.61 pp |
| 2021 | 2021-09-30 | 33.39% | −12.15 pp |
| 2020 | 2020-09-30 | 45.55% | — |
Universe Pharmaceuticals return on equity trends
Over the last five fiscal years, Universe Pharmaceuticals's return on equity decreased from 45.55% to −7.23%, a change of −52.78 percentage points.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Universe Pharmaceuticals source filings ↗